Naxitamab

3 trials 2 recruiting Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

0 Completed trials

3 Sponsors

6 Countries

Phase II

Phase II: 3

Indications tested

Ewing's sarcoma 1 Neuroblastoma recurrent 1

Sponsors using this IMP

Fundacio Sant Joan De Deu 1 Instytut Matki I Dziecka 1 Y-mAbs Therapeutics A/S 1

All trials

3 total

Study to find out whether adding the medicine Naxitamab to standard treatment could help children and teenagers who have just been diagnosed… Pending

2025-524140-35-00 Phase II 1 country Fundacio Sant Joan De Deu
A Phase 3 Trial of Antibody hu3F8 and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in High-Risk Neuroblastoma Patients with Pri… Recruiting

2023-508587-29-00 Phase II 5 countries Y-mAbs Therapeutics A/S
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma. Recruiting

2024-514441-11-00 Phase II 1 country Instytut Matki I Dziecka

Showing 1–3 of 3 trials

← All drugs A–Z